Low molecular weight heparin for repeated pregnancy loss: is it based on solid evidence?
Lindqvist
P G
PG
Department of Obstetrics and Gynecology, Malmö University Hospital, Ing 74 20502, Malmö, Sweden. pelle.lindqvist@obst.mas.lu.se
Merlo
J
J
D000026:Abortion, Habitual / Q000188:drug therapy / Q000517:prevention & control*; D002985:Clinical Protocols / Q000592:standards; D002986:Clinical Trials as Topic / Q000592:standards; D017984:Enoxaparin / Q000627:therapeutic use; D005260:Female; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use*; D006801:Humans; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000188:drug therapy
D017984:Enoxaparin; D006495:Heparin, Low-Molecular-Weight